Key facts
- This page summarizes Sid Singh's Form 4 filing for EQUIFAX INC (EFX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 Feb 2022, 16:53.
Sid Singh - 11 Feb 2022 Form 4 Insider Report for EQUIFAX INC (EFX)
- Reporting relationship
- President - USIS
- Issuer ticker
- EFX
- Reported as of
- 11 Feb 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Feb 2022, 16:53:22 UTC
- Prior SEC filing
- 01 Oct 2021
- Next SEC filing
- 24 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/Lisa Stockard as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sid Singh filed Form 4 for EQUIFAX INC (EFX) on 15 Feb 2022.
Change
- Previous filing in this sequence was filed on 01 Oct 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EFX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +3,112
- Change %
- +31%
- Price
- $0.000000
- Shares after
- 13,313
- Date
- 11 Feb 2022
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EFX
transaction
Derivative
Stock Option/Right to Buy
Award
- Transaction value
- $0
- Shares
- +12,434
- Change %
- Price
- $0.000000
- Shares after
- 12,434
- Date
- 11 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,434
- Exercise price
- $225.00
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/11/2025.
Footnote F2
Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
Footnote F3
Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/11/2023.